CVS up 3% premarket on Q3 beat, non-GAAP EPS guidance raise – Seeking Alpha

CVS Health (NYSE:CVS) Q3 results:
Revenues: $64,810M (+36.5%); Pharmacy Services: $36,018M (+6.4%); Retail/LTC: $21,466M (+2.9%); Healthcare Benefits: $17,181M (+3.9%).
Operating income: $2,928M (+13.8%); net income: $1,529M (+10.0%); non-GAAP net income: $…

Click here to view the original article.